{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Escapes", "lead_paragraph": "THE ripples of the yacht's reflection gleam white in the water. Its silhouette is sleek and streamlined. Inside, the quarters are the size of a modest apartment, with three bedrooms, three bathrooms and accommodations for the captain. Amenities include flat-screen television sets and bone china. And it can be had for $186,500 upfront. Just not all the time. The yacht is the Avignon, available for time sharing and managed by YachtSmart, which its owners say is the first business to offer time share contracts for large luxury yachts. In the spirit of NetJets Inc., a company that allows a fairly frequent flier to buy a share in a jet, YachtSmart offers fractional ownership in a boat -- the 62-foot Avignon, a Fairline Squadron 62, which docked at Liberty Harbor in New Jersey during a recent promotional tour. A holder of one share gets four and a half weeks a year on the yacht, with dockage, cleaning, maintenance, insurance and a captain at the wheel included. All the shareholder has to worry about is scheduling time on the yacht, which can be taken a weekend at a time or in segments of up to two weeks long.", "headline": {"main": "Buy a Yacht, Without Going Overboard", "kicker": "DRIVING"}, "abstract": "Article on YachtSmart, year-old company founded by Jonathan Metcalfe and Philip Burroughs that sells time shares on $1.85 million yacht Avignon for $186,500 up front and monthly management fee of $1,450; each share holder gets four and half weeks a year on yacht with dockage, cleaning, maintenance, insurance and captain; photos (M)", "print_page": "8", "word_count": 740, "_id": "4fd21f848eb7c8105d7a23d9", "snippet": "THE ripples of the yacht's reflection gleam white in the water. Its silhouette is sleek and streamlined. Inside, the quarters are the size of a modest apartment, with three bedrooms, three bathrooms and accommodations for the captain. Amenities...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/02/travel/driving-buy-a-yacht-without-going-overboard.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "METCALFE, JONATHAN"}, {"name": "persons", "value": "BURROUGHS, PHILIP"}, {"name": "organizations", "value": "YACHTSMART"}, {"name": "subject", "value": "TIME-SHARING"}, {"name": "subject", "value": "BOATS AND BOATING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Catherine", "lastname": "CHATHAM"}], "original": "By CATHERINE CHATHAM"}, "document_type": "article", "pub_date": "2002-08-02T00:00:00Z", "section_name": null}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Aetna reported a tenfold jump in profits in the second quarter yesterday as its struggle to recover from a money-losing spiral began to show signs of success. The company earned $108.2 million, or 70 cents a share, compared with $10.6 million, or 7 cents a share, a year earlier. Revenue fell to $5.06 billion from $6.5 billion as Aetna shed unprofitable business.", "headline": {"main": "Aetna Strategy Results in Tenfold Jump in Quarterly Profit"}, "abstract": "Aetna reports tenfold jump in profits in second quarter as its struggle to recover from money-losing spiral begins to show signs of success; company earns $108.2 million, or 70 cents a share, compared with $10.6 million, or 7 cents a share, year earlier (M)", "print_page": "10", "word_count": 544, "_id": "4fd21f848eb7c8105d7a23de", "snippet": "Aetna reported a tenfold jump in profits in the second quarter yesterday as its struggle to recover from a money-losing spiral began to show signs of success.    The company earned $108.2 million, or 70 cents a share, compared with $10.6 million, or...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/02/business/aetna-strategy-results-in-tenfold-jump-in-quarterly-profit.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "AETNA INC"}, {"name": "subject", "value": "COMPANY REPORTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By JOSEPH B. TREASTER"}, "document_type": "article", "pub_date": "2002-08-02T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Talks between the White House and the Senate on a bill to define patients' rights collapsed today, significantly reducing the chances that the government will impose new standards on health insurance companies and health maintenance organizations this year. Ultimately, senators said, they could not reach agreement with the White House on creation of a federal right for patients to sue for injuries caused by the decisions of an H.M.O.", "headline": {"main": "White House and Senate Hit Impasse on Patients' Rights"}, "abstract": "Talks between White House and Senate on patients' rights bill collapse; bill approved by Senate last year would allow patients to sue in federal or state courts, broad right opposed by Pres Bush; authors, Sens Edward Kennedy, John Edwards and John McCain, began quiet negotiations with White House last November but now abandon efforts after they are unable to get meeting with Bush to resolve final issues; photo (M)", "print_page": "17", "word_count": 781, "_id": "4fd21f848eb7c8105d7a23d1", "snippet": "Talks between the White House and the Senate on a bill to define patients' rights collapsed today, significantly reducing the chances that the government will impose new standards on health insurance companies and health maintenance organizations...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/02/us/white-house-and-senate-hit-impasse-on-patients-rights.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KENNEDY, EDWARD M"}, {"name": "persons", "value": "EDWARDS, JOHN"}, {"name": "persons", "value": "MCCAIN, JOHN"}, {"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS AND MANAGED CARE"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-08-02T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "An Analysis; News Analysis", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Just a few days ago, the 107th Congress was racking up a string of unexpected achievements on corporate responsibility and trade despite divided party control. But the collapse of prescription drug legislation in the Senate showed that other issues remain stubbornly intractable. This conflicting impulse toward compromise on some issues and confrontation on others has been a hallmark of this Congress, which has come up with an unexpected list of accomplishments for both President Bush and the Democrats, yet still has a substantial unfinished agenda. In addition, there are powerful forces tugging in each direction as the midterm elections approach.", "headline": {"main": "With Unfinished Agenda, Congress Juggles Compromise and Confrontation"}, "abstract": "News analysis of congressional session reports that, despite string of unexpected achievements on corporate responsibility and trade, other issues remain stubbornly intractable, as seen in collapse of prescription drug legislation; conflicting impulse toward compromise on some issues and confrontation on others has been hallmark of 107th Congress; Republicans who control House and Democrats running Senate each have symbolic need to show voters legislative success, but deep ideological differences still pull them apart (M)", "print_page": "17", "word_count": 977, "_id": "4fd21f848eb7c8105d7a23cd", "snippet": "Just a few days ago, the 107th Congress was racking up a string of unexpected achievements on corporate responsibility and trade despite divided party control. But the collapse of prescription drug legislation in the Senate showed that other issues...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/02/us/with-unfinished-agenda-congress-juggles-compromise-and-confrontation.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "ELECTIONS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Alison", "lastname": "MITCHELL"}], "original": "By ALISON MITCHELL"}, "document_type": "article", "pub_date": "2002-08-02T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign Desk", "lead_paragraph": "The Senate agreed today not to interfere in trade deals negotiated by the White House, giving final approval to an accord requested by two presidents over eight years. Bush administration officials said they would immediately use the long-sought authority to accelerate trade talks stalled for years by partisan differences. In a last vote before leaving Washington's heat for an August recess, senators from both parties voted 64 to 34 to give President Bush the negotiating authority that members of Congress had denied to President Clinton for much of his tenure. Last week, a more divided House of Representatives agreed to the same bill, which now goes to the White House for the president's signature.", "headline": {"main": "Senate Grants Bush Authority On Trade Deals"}, "abstract": "Senate votes, 64 to 34, to give Pres Bush fast-track authority on trade deals; administration can now negotiate with countries and trading blocs without fear that details will later be changed; Congress retains right under five-year agreement to veto any deal administration makes; majority of Democrats vote against bill, and some senators express strong reservations about effect that liberalized trade would have on jobs of American workers; Pres Bush, who now has trade authority denied to Pres Clinton for much of his tenure, calls action 'historic moment' (M)", "print_page": "1", "word_count": 776, "_id": "4fd21ee48eb7c8105d7a13bc", "snippet": "The Senate agreed today not to interfere in trade deals negotiated by the White House, giving final approval to an accord requested by two presidents over eight years. Bush administration officials said they would immediately use the long-sought...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/02/world/senate-grants-bush-authority-on-trade-deals.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, BILL"}, {"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "David", "lastname": "FIRESTONE"}], "original": "By DAVID FIRESTONE"}, "document_type": "article", "pub_date": "2002-08-02T00:00:00Z", "section_name": "World; Front Page"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Senate today killed legislation to provide prescription drug benefits promised to the elderly by politicians of both parties. But it overwhelmingly passed a bill intended to give all Americans greater access to low-cost generic versions of brand-name medicines. Given the ideological divisions revealed in the Senate debate, lawmakers said the elderly might have to wait several years for Medicare coverage of the drugs they take for heart disease, stroke, arthritis and other ailments. The measure on generic medicines faces an uncertain future in the House.", "headline": {"main": "SENATE KILLS PLAN FOR DRUG BENEFITS THROUGH MEDICARE"}, "abstract": "Senate kills bill to provide prescription drug benefits promised to elderly by politicians of both parties, but overwhelmingly passes bill intended to give all Americans greater access to low-cost generic versions of brand-name medicines; senators of both parties say they will have to answer to voters this fall for their failure to deliver Medicare drug benefits; each party blames other; measure on generic medicines faces uncertain future in House; defeat of Medicare measure, by vote of 50 to 49, appears to be major setback for Democrats, who vow to keep fighting; generic drug bill passes by vote of 78 to 21; Congressional Budget Office estimates that generic drug bill would reduce total spending on prescription drugs by $60 billion, or 1.3 percent, over next 10 years; photo; chart with major provisions of measure (M)", "print_page": "1", "word_count": 1359, "_id": "4fd2362b8eb7c8105d7c7f9f", "snippet": "The Senate today killed legislation to provide prescription drug benefits promised to the elderly by politicians of both parties. But it overwhelmingly passed a bill intended to give all Americans greater access to low-cost generic versions of...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/01/us/senate-kills-plan-for-drug-benefits-through-medicare.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "CONGRESSIONAL BUDGET OFFICE"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-08-01T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "One-third of the elderly in this country have no prescription drug insurance at all, and many of the rest are poorly covered. Yet despite repeated promises stretching back to the 2000 election campaign, the 100 members of the United States Senate could not muster the will to pass even a stripped-down version of a drug bill that would have helped millions of America's neediest citizens. It was only modestly consoling that the Senate then approved the underlying bill to which the drug benefit had been attached -- a useful proposal to ease access to cheaper generic drugs. The defeat greatly diminishes the possibility that Congress will do anything on prescription drugs before the midterm election campaign begins in earnest. Even on the off chance that the Senate approves a bill after its August recess, there will be scant time to reconcile it with a weak House bill passed in June. At the same time, yesterday's disappointing vote greatly enlarges the prospect for the kind of finger-pointing that all candidates love. House Republicans will be quick to blame the ''Democratic-controlled Senate'' and Democrats will lament ''obstructionist Republicans.''", "headline": {"main": "Drug Coverage Failure"}, "abstract": "Editorial scores 100 members of US Senate who could not muster will to pass even stripped-down drug bill to help millions of elderly Americans who have little or no coverage for expensive medications; wonders that leadership of richest nation on earth, from White House to Capitol Hill, cannot summon imagination or compassion to help", "print_page": "24", "word_count": 341, "_id": "4fd2362b8eb7c8105d7c7fb1", "snippet": "One-third of the elderly in this country have no prescription drug insurance at all, and many of the rest are poorly covered. Yet despite repeated promises stretching back to the 2000 election campaign, the 100 members of the United States Senate...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/01/opinion/drug-coverage-failure.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "EDITORIALS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": null, "document_type": "article", "pub_date": "2002-08-01T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The state's three largest drugstore chains say they are withdrawing from its Medicaid program, meaning poor and disabled people could soon be shut out of more than half of the state's pharmacies. The chains -- CVS, Walgreens and Brooks Pharmacy -- blamed state budget cuts that reduce reimbursement rates for Medicaid prescriptions by 11 percent.", "headline": {"main": "National Briefing | New England: Massachusetts: Pullout From Medicaid"}, "abstract": "Three largest drug chains in Massachusetts--CVS, Walgreens and Brooks Pharmacy--are withdrawing from state's Medicaid program; blame budget cuts that have reduced reimbursement (S)", "print_page": "19", "word_count": 55, "_id": "4fd21f868eb7c8105d7a250a", "snippet": "The state's three largest drugstore chains say they are withdrawing from its Medicaid program, meaning poor and disabled people could soon be shut out of more than half of the state's pharmacies. The chains -- CVS, Walgreens and Brooks Pharmacy --...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/01/us/national-briefing-new-england-massachusetts-pullout-from-medicaid.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "MASSACHUSETTS"}, {"name": "organizations", "value": "WALGREEN CO"}, {"name": "organizations", "value": "BROOKS PHARMACY"}, {"name": "organizations", "value": "CVS DRUG STORES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": null, "document_type": "article", "pub_date": "2002-08-01T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Martin Ebner, the financier who spent the 1990's shaking up Switzerland's clubby corporations and coaxing the famously thrifty Swiss to invest in stocks, yielded today to a slumping market and gave up control of four main investment funds. His holding company, BZ Group Holding, said it had sold the controlling stake in four listed companies, with portfolios worth $2 billion, to the Zurich Cantonal Bank, a state-owned regional bank. No price for the sale was given, but analysts said the funds had lost as much as half their previous value in recent months, as holdings in the Credit Suisse Group and the giant engineering group ABB Ltd. plummeted in value.", "headline": {"main": "Financier Who Shook Up the Swiss Is Himself Shaken Up"}, "abstract": "Martin Ebner, financier who spent 1990's shaking up Switzerland's clubby corporations and coaxing famously thrifty Swiss to invest in stocks, yields to slumping market and gives up control of four main investment funds; his holding company, BZ Group Holding, says it had sold controlling stake in four listed companies, with portfolios worth $2 billion, to Zurich Cantonal Bank; photo (M)", "print_page": "1", "word_count": 784, "_id": "4fd238e18eb7c8105d7cc125", "snippet": "Martin Ebner, the financier who spent the 1990's shaking up Switzerland's clubby corporations and coaxing the famously thrifty Swiss to invest in stocks, yielded today to a slumping market and gave up control of four main investment funds.    His...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/01/business/financier-who-shook-up-the-swiss-is-himself-shaken-up.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "EBNER, MARTIN"}, {"name": "glocations", "value": "SWITZERLAND"}, {"name": "organizations", "value": "ZURICH CANTONAL BANK"}, {"name": "organizations", "value": "BZ GROUP"}, {"name": "subject", "value": "STOCKS AND BONDS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Elizabeth", "lastname": "OLSON"}], "original": "By ELIZABETH OLSON"}, "document_type": "article", "pub_date": "2002-08-01T00:00:00Z", "section_name": "Business"}], "meta": {"hits": 29, "offset": 20, "time": 61}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}